Author:
Rojas Camilo,Li Ying,Zhang Jie,Stathis Marigo,Alt Jesse,Thomas Ajit G.,Cantoreggi Sergio,Sebastiani Silvia,Pietra Claudio,Slusher Barbara S.
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Subject
Pharmacology,Molecular Medicine
Reference20 articles.
1. A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy
2. Pharmacological characterization of RS 25259-197, a novel and selective 5-HT3 receptor antagonist, in vivo;Eglen;Br J Pharmacol,1995
3. Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist
4. Characteristics of [14C]Guanidinium Accumulation in NG 108-15 Cell Exposed to Serotonin 5-HT3Receptor Ligands and Substance P
5. Effects of various 5-HT3 receptor antagonists, granisetron, ondansetron, ramosetron and azasetron on serotonin (5-HT) release from the ferret isolated ileum;Endo;Res Commun Mol Pathol Pharmacol,1999
Cited by
116 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献